Clinical trial
Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo…
NCT00110786 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00110786 |
|---|---|
| Title | Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy |
| Official title | A Double Blind Study to Investigate the Clinical Efficacy and Safety of Ragweed MATAMPL (Allergy Therapeutics®), Pollinex®-R (Allergy Therapeutics®) and Placebo in Patients With Seasonal Allergic Rhinitis With Ragweed Allergy, in an Environmental Exposure Chamber (EEC) Model, With Follow-Up During a… |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Ragweed MATAMPL |
| Enrollment | 240 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | May 16, 2005 |
| Last update posted | Jun 17, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: